Veritas Genetics
Whole genome clarity for life
Provides genome sequencing, genetic diagnostics, oncology, cardiology, pharmacogenomics, and reproductive medicine services. It operates as a subsidiary focusing on clinical genomics.
How We Help
Problem Statement
To empower healthcare professionals and consumers with personalized health data for accurate diagnosis, personalized prevention, and improved healthcare decision-making.
Core Technology
Whole Exome and Genome Sequencing
Key Differentiators
Offers detailed insights into genetic information through whole exome and genome sequencing.; Focuses on a predictive, preventive, and personalized model of healthcare.
Clinical Focus
Pharmacogenomics; Reproductive Medicine; Clinical Genomics
Company Info
- Business Model
- Hybrid
- Total Funding
- 4,600,000
- Website
- www.veritasgenetics.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Peer-reviewed study in Scientific Reports demonstrating whole-genome sequencing (WGS) clinical utility in primary care (104 asymptomatic participants). CLIA-certified, CAP-accredited laboratory (ISO certified). myNewborn analyzes 390+ disease-related genes. Pharmacogenomic and polygenic risk scoring validated in clinical practice.
MedStartr Index Score
?What do you think of Veritas Genetics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.